iQIYI shorts build as stock breaks below $1

IQ crossed an uncomfortable threshold this week. The stock closed at $0.9212 on Tuesday, down 7.1% on the week and nearly 9% over the past month, pushing below the $1 mark and raising the stakes ahead of a Q3 earnings release on November 20.

Short sellers have been quietly adding pressure. Short interest has climbed 3.1% over the past week to 7.5% of the free float, roughly 72.6 million shares, extending a trend that has seen shorts grow around 4.5% over the past month. The borrow market, however, is not especially stressed. Availability has eased back to 66%, well above the 52-week low of 36%, meaning there is ample room for new shorts to be established without squeezing existing positions. Borrowing costs are a negligible 0.73% annualised, near multi-month lows. The overall picture is one of methodical short accumulation rather than a crowded, high-conviction squeeze setup. ORTEX's short score of 77.7 out of 100 reflects the elevated positioning, ranking IQ in the 2nd percentile on short score among its peers, meaning almost every comparable stock carries less bearish pressure.

The Street is cautious, and the data behind analyst coverage deserves scrutiny. JP Morgan lowered its target sharply from $2.20 to $1.20 in August after Q2 results, maintaining a Neutral rating. With the stock now at $0.92, even that reduced target implies meaningful upside, but the direction of travel among analysts has been downward for over a year. Older upgrades from UBS and Jefferies, both from August 2025, carry targets of $3.32 and $2.50 respectively; those targets are now so far above the current price that they describe a company the market no longer recognises. The mean consensus target of $8.97 cited in the data almost certainly reflects stale coverage or a currency mismatch and should not be taken at face value. On valuation, the price-to-book has drifted to 0.46, down 7% over 30 days, while EV/EBITDA sits at 1.3x. Factor scores tell a split story: EPS surprise ranks in the 99th percentile, and 30-day EPS momentum ranks 96th, suggesting estimate revisions have been moving sharply upward in the near term, even as the stock falls.

Options positioning is actually leaning constructive relative to recent history. The put/call ratio of 0.53 is just below its 20-day average of 0.55, running about 1.1 standard deviations below the mean. That places options sentiment in the more call-heavy end of its recent range, a contrast to the heavy put-buying seen in mid-September when the PCR was above 0.90. The divergence between options sentiment and the rising short interest is the clearest tension in the current setup: derivatives traders are not hedging particularly hard, while the short book is still growing.

The ownership register adds one notable data point. T. Rowe Price, which had held 17.7% of the company, has filed a 13G/A showing the position cut to 8.8%. That is a significant reduction from a long-only institution and was disclosed in September. As with all Schedule 13D/G filings, the position is as last disclosed around the 5% threshold; holders dropping below 5% may exit without a further filing, so the actual current position could be lower still. Baidu remains the anchor shareholder with 45% of the company, providing structural stability but also limiting free-float liquidity.

The next earnings print on November 20 is the focal point. The last Q2 report in August produced a one-day fall of 15% and a five-day decline of 22.6%, the most severe reaction in the available history. With the stock now sub-$1, the degree to which content monetisation and subscriber trends can reverse that narrative is the defining question heading into the print.